OTIC Otonomy Inc

Price (delayed)

$1.92

Market cap

$108.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.82

Enterprise value

$55.25M

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop ...

Highlights
Otonomy's quick ratio has surged by 60% QoQ
Otonomy's EPS has increased by 43% YoY and by 18% QoQ
Otonomy's gross margin has increased by 46% QoQ but it has decreased by 24% YoY
The revenue has declined by 41% year-on-year but it has increased by 12% since the previous quarter
The net income has declined by 4.7% year-on-year and by 2.3% since the previous quarter

Key stats

What are the main financial stats of OTIC
Market
Shares outstanding
56.68M
Market cap
$108.83M
Enterprise value
$55.25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.4
Price to sales (P/S)
552.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
242.33
Earnings
Revenue
$228,000
EBIT
-$44.68M
EBITDA
-$43.75M
Free cash flow
-$41.28M
Per share
EPS
-$0.82
Free cash flow per share
-$0.63
Book value per share
$1.37
Revenue per share
$0
TBVPS
$1.76
Balance sheet
Total assets
$115.42M
Total liabilities
$37.77M
Debt
$32.22M
Equity
$77.65M
Working capital
$90.52M
Liquidity
Debt to equity
0.41
Current ratio
11.25
Quick ratio
11.16
Net debt/EBITDA
1.22
Margins
EBITDA margin
-19,189.5%
Gross margin
-265.4%
Net margin
-20,278.9%
Operating margin
-19,639.9%
Efficiency
Return on assets
-43%
Return on equity
-67.2%
Return on invested capital
-60.8%
Return on capital employed
-41.9%
Return on sales
-19,596.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OTIC stock price

How has the Otonomy stock price performed over time
Intraday
0.52%
1 week
13.61%
1 month
20%
1 year
-47.83%
YTD
-70.32%
QTD
0%

Financial performance

How have Otonomy's revenue and profit performed over time
Revenue
$228,000
Gross profit
-$605,000
Operating income
-$44.78M
Net income
-$46.24M
Gross margin
-265.4%
Net margin
-20,278.9%
The net margin has shrunk by 78% YoY but it is up by 9% QoQ
The company's operating margin has shrunk by 75% YoY but it rose by 9% QoQ
Otonomy's gross margin has increased by 46% QoQ but it has decreased by 24% YoY
The revenue has declined by 41% year-on-year but it has increased by 12% since the previous quarter

Growth

What is Otonomy's growth rate over time

Valuation

What is Otonomy stock price valuation
P/E
N/A
P/B
1.4
P/S
552.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
242.33
Otonomy's EPS has increased by 43% YoY and by 18% QoQ
The P/B is 50% below the last 4 quarters average of 2.8 and 33% below the 5-year quarterly average of 2.1
The equity is up by 39% since the previous quarter
OTIC's price to sales (P/S) is 76% higher than its 5-year quarterly average of 314.5 but 24% lower than its last 4 quarters average of 726.0
The revenue has declined by 41% year-on-year but it has increased by 12% since the previous quarter

Efficiency

How efficient is Otonomy business performance
Otonomy's return on sales has shrunk by 79% YoY but it has increased by 9% QoQ
The ROE has grown by 46% YoY and by 19% from the previous quarter
The ROA has grown by 25% YoY and by 10% from the previous quarter
OTIC's ROIC is down by 2.4% YoY

Dividends

What is OTIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OTIC.

Financial health

How did Otonomy financials performed over time
OTIC's current ratio has soared by 199% YoY and by 56% QoQ
The total assets has soared by 89% year-on-year and by 24% since the previous quarter
The debt is 59% lower than the equity
The debt to equity has shrunk by 75% YoY and by 28% QoQ
The equity is up by 39% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.